Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: extrication (1)

Capecitabine-Cisplatin

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE and CISPLATIN Regimen • Gastrointestinal Cancer (upper) – Capecitabine and Cisplatin Indication • First line therapy of inoperable
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin.pdf

Fluorouracil-Folinic acid(MdG)-Irinotecan-Panitumumab

Description: Chemotherapy Protocol COLORECTAL CANCER FLUOROURACIL, FOLINIC ACID (Modified de Gramont), IRINOTECAN and PANITUMUMAB (FOLFIRI-Panitumumab) This protocol may require funding Regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Fluorouracil-Folinic-acidMdG-Irinotecan-Panitumumab.pdf

Cetuximab-Irinotecan (14 day)

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-IRINOTECAN (14 day) This regimen may require funding Regimen • Colorectal Cancer–Cetuximab-Irinotecan (14 day) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Irinotecan14day.pdf

Capecitabine-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE and IRINOTECAN (XELIRI) Regimen • Colorectal Cancer– Capecitabine-Irinotecan (XELIRI) Indication • Treatment of advanced colorectal cancer • WHO
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Irinotecan.pdf

Bevacizumab-Fluorouracil-Folinic Acid-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN This regimen may require funding Regimen • Colorectal Cancer – Bevacizumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Fluorouracil-FolinicAcid-Irinotecan.pdf

Aflibercept-Fluorouracil-Folinic Acid-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER AFLIBERCEPT-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN This regimen may require funding Regimen • Colorectal Cancer – Aflibercept
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Aflibercept-Fluorouracil-Folinic-Acid-Irinotecan.pdf

Anastrozole-Ribociclib

Description: Chemotherapy Protocol Breast Cancer Anastrozole-Ribociclib Regimen • Breast Cancer – Anastrozole-Ribociclib Indication • Ribociclib in combination with an aromatase inhibitor is indicated
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Anastrozole-Ribociclib.pdf

PIS COVID-19 immsup adults V2.1

Description: Participant Information Study Title: Coronavirus infection in immunosuppressed children and adults. Chief Investigator: H. de Graaf Principal investigators: H. de Graaf
Url: /Media/Southampton-Clinical-Research/COVID-19/ImmunoCOVID/PIS-COVID-19-immsup-adults-V2.1.pdf

ImmunoCOVID19 info for parents or carers and children aged 16-17

Description: Participant Information for parents/carers and children aged 16-17 years Study Title: Coronavirus infection in primary or secondary immunosuppressed children
Url: /Media/Southampton-Clinical-Research/Downloads/Immunocovid/ImmunoCOVID19-info-for-parents-or-carers-and-children-aged-16-17.pdf

PIS COVID-19 immsup child - over 16 yrs and parents V1.6

Description: Participant Information for parents/carers and children aged 16-17 years Study Title: Coronavirus infection in primary or secondary immunosuppressed children
Url: /Media/Southampton-Clinical-Research/COVID-19/PIS-COVID-19-immsup-child-over-16-yrs-and-parents-V1.6.pdf

251 to 260 of 322

Previous … 24 25 26 27 28 … Next